Filing Details
- Accession Number:
- 0001562180-19-004025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-22 16:29:37
- Reporting Period:
- 2019-06-30
- Accepted Time:
- 2019-07-22 16:29:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590877 | Regenxbio Inc. | RGNX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1521123 | J. Patrick Christmas | C/O Regenxbio Inc. 9600 Blackwell Road, Suite 210 Rockville MD 20850 | Svp, General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-30 | 52 | $36.83 | 3,058 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2019-07-18 | 100 | $19.50 | 3,158 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-07-18 | 100 | $50.00 | 3,058 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-07-19 | 4,900 | $19.50 | 7,958 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-07-19 | 4,900 | $50.03 | 3,058 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-07-18 | 100 | $0.00 | 100 | $19.50 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-07-19 | 4,900 | $0.00 | 4,900 | $19.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,541 | 2027-01-03 | No | 4 | M | Direct | |
| 4,641 | 2027-01-03 | No | 4 | M | Direct |
Footnotes
- The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the REGENXBIO Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of January 1, 2019 through June 30, 2019. This transaction is exempt under Rule 16b-3(c).
- In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on January 2, 2019.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- The previously granted option, representing a right to purchase a total of 11,100 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.
Billionaire Hedge Funds
